In contrast, Pérez-Mancera PA, et al. found that low USP9X protein and mRNA expression in pancreatic ductal adenocarcinoma (PDA) correlated with poor survival after surgery and USP9X levels were inversely associated with metastatic burden in advanced disease [21]. This evidence concerns the gene USP9X and pancreatic ductal adenocarcinoma.